Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025)

Collegium Pharmaceutical's (COLL) quarterly Other Operating Expenses came in at -$19000.0 in Q4 2025, up 99.85% year-on-year from -$9507.3 in Q4 2024, and up 99.83% quarter-over-quarter from -$10.9 million in Q3 2025.

Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025) Analysis & Trends

Collegium Pharmaceutical's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$19000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 99.85% year-over-year to -$19000.0 in Q4 2025; TTM through Mar 2026 was -$21.1 million, a 49.84% increase from a year earlier, with the FY2025 full-year figure at -$1.2 million, up 96.77% from the prior year.
  • Other Operating Expenses improved to -$19000.0 in Q4 2025 per COLL's latest filing, from -$10.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$19000.0 in Q4 2025 and bottomed at -$14.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Collegium Pharmaceutical 1.14 Bn 853.50 Mn 117.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -19,000.00
Sep 30, 2025 -10.92 Mn
Jun 30, 2025 -10.16 Mn
Mar 31, 2025 -14.08 Mn
Dec 31, 2024 -12.39 Mn
Sep 30, 2024 -7.80 Mn
Jun 30, 2024 -7.81 Mn
Mar 31, 2024 -8.62 Mn
Dec 31, 2018 29.73 Mn
Sep 30, 2018 46.01 Mn
Jun 30, 2018 46.84 Mn
Mar 31, 2018 43.11 Mn
Dec 31, 2017 1.09 Mn
Sep 30, 2017 553,000.00
Jun 30, 2017 577,000.00
Mar 31, 2017 371,000.00
Dec 31, 2016 184,000.00
Sep 30, 2016 29,000.00